Skip to content

Schrodinger SDGR EPS (Basic)

EPS (Basic) at other companies

Cadence Design Systems logo
Cadence Design SystemsCDNS
$1.23+21.8%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
-$0.22+56.0%
Absci Corporation logo
Absci CorporationABSI
-$0.19+9.5%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$0.14+6.7%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
-$0.41+10.9%
Septerna, Inc. logo
Septerna, Inc.SEPN
-$0.19+61.2%

Other financials

Income statement

See full
Revenue$58.6M-1.6%
Gross profit$29.5M-5.1%
Operating income-$48.8M+4.1%
Net income-$60.0M-0.4%
EPS (diluted)-$0.81+1.2%

Balance sheet

See full
Cash & equivalents$267.7M-20.7%
Total debt$107.0M-7.9%
Total equity$313.5M-16.1%
Total assets$634.2M-14.6%

Cash flow

See full
Operating cash flow-$14.8M-110%
CapEx$2.5M+321%
Free cash flow-$17.3M-112%

Valuation

See full
Market cap$1.15B-41.8%
Enterprise value$984.71M-44.4%
P/S4.5×-4.0×

Profitability

See full
Gross margin55.3%-7.3pp
Operating margin-64.7%-12.0pp
Net margin-68.5%
FCF margin9.6%+5.1pp

Returns & leverage

See full
Return on equity-45.7%
Debt / equity0.3×0.0×
Current ratio2.7×-0.7×

Where this comes from

Reported directly by Schrodinger in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: Schrodinger’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Schrodinger's eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Schrodinger's EPS (basic)?
Schrodinger (SDGR) reported EPS (basic) of -$0.81 in Q1 2026.
How has Schrodinger's EPS (basic) changed year-over-year?
Schrodinger's EPS (basic) increased by 1.2% year-over-year, from -$0.82 to -$0.81.
What is the long-term trend for Schrodinger's EPS (basic)?
Over 2 years (2021 to 2024), Schrodinger's EPS (basic) has grown at a 34.5% compound annual growth rate (CAGR), from -$1.42 to -$2.57.
What does EPS (basic) mean?
Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.